Authors:
Proudfoot, JR
Betageri, R
Cardozo, M
Gilmore, TA
Glynn, S
Hickey, ER
Jakes, S
Kabcenell, A
Kirrane, TM
Tibolla, AK
Lukas, S
Patel, UR
Sharma, R
Yazdanian, M
Moss, N
Beaulieu, PL
Cameron, DR
Ferland, JM
Gauthier, J
Gillard, J
Gorys, V
Poirier, M
Rancourt, J
Wernic, D
Llinas-Brunet, M
Citation: Jr. Proudfoot et al., Nonpeptidic, monocharged, cell permeable ligands for the p56lck SH2 domain, J MED CHEM, 44(15), 2001, pp. 2421-2431
Authors:
Llinas-Brunet, M
Bailey, M
Fazal, G
Ghiro, E
Gorys, V
Goulet, S
Halmos, T
Maurice, R
Poirier, M
Poupart, MA
Rancourt, J
Thibeault, D
Wernic, D
Lamarre, D
Citation: M. Llinas-brunet et al., Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: Towards smaller inhibitors, BIOORG MED, 10(20), 2000, pp. 2267-2270
Authors:
Beaulieu, PL
Anderson, PC
Cameron, DR
Croteau, G
Gorys, V
Grand-Maitre, C
Lamarre, D
Liard, F
Paris, W
Plamondon, L
Soucy, F
Thibeault, D
Wernic, D
Yoakim, C
Pav, S
Tong, L
Citation: Pl. Beaulieu et al., 2 ',6 '-dimethylphenoxyacetyl: A new achiral high affinity P-3-P-2 ligand for peptidomimetic-based HIV protease inhibitors, J MED CHEM, 43(6), 2000, pp. 1094-1108
Authors:
Llinas-Brunet, M
Beaulieu, PL
Cameron, DR
Ferland, JM
Gauthier, J
Ghiro, E
Gillard, J
Gorys, V
Poirier, M
Rancourt, J
Wernic, D
Citation: M. Llinas-brunet et al., Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56(lck) SH2 domain, J MED CHEM, 42(4), 1999, pp. 722-729
Authors:
Beaulieu, PL
Cameron, DR
Ferland, JM
Gauthier, J
Ghiro, E
Gillard, J
Gorys, V
Poirier, M
Rancourt, J
Wernic, D
Llinas-Brunet, M
Betageri, R
Cardozo, M
Hickey, ER
Ingraham, R
Jakes, S
Kabcenell, A
Kirrane, T
Lukas, S
Patel, U
Proudfoot, J
Sharma, R
Tong, L
Moss, N
Citation: Pl. Beaulieu et al., Ligands for the tyrosine kinase p56(lck) SH2 domain: Discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements, J MED CHEM, 42(10), 1999, pp. 1757-1766